Tacrolimus and mycophenolate mofetil in renal transplant recipients: One year results of a multicenter, randomized dose ranging trial

被引:21
|
作者
Miller, J [1 ]
机构
[1] Univ Miami, Sch Med, Kidney Transplant Program, Miami, FL 33136 USA
关键词
D O I
10.1016/S0041-1345(98)01625-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:276 / 277
页数:2
相关论文
共 50 条
  • [1] FK 506 and mycophenolate mofetil in renal transplant recipients: Six-month results of a multicenter, randomized dose ranging trial
    Mendez, R
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1287 - 1289
  • [2] A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone mycophenolate mofetil in renal transplant recipients
    Shapiro, R
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Marsh, JM
    McCauley, J
    Johnston, J
    Randhawa, P
    Irish, W
    Gritsch, HA
    Naraghi, R
    Hakala, TR
    Fung, JJ
    Starzl, TE
    [J]. TRANSPLANTATION, 1999, 67 (03) : 411 - 415
  • [3] Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results
    Reich, DJ
    Clavien, PA
    Hodge, EE
    [J]. TRANSPLANTATION, 2005, 80 (01) : 18 - 25
  • [4] Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients
    Forsythe, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 69S - 71S
  • [5] Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function
    Liu, B
    Lin, ZB
    Ming, CS
    Zhang, WJ
    Chen, ZS
    Sha, B
    Zeng, FJ
    Chen, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 87 - 88
  • [6] Evaluation of renal function in liver transplant recipients receiving daclizumab (zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus reaimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
    Yoshida, EM
    Marotta, PJ
    Greig, PD
    Kneteman, NM
    Marleau, D
    Cantarovich, M
    Peltekian, KM
    Lilly, LB
    Scudamore, CH
    Bain, VG
    Wall, WJ
    Roy, A
    Balshaw, RE
    Barkun, JST
    [J]. LIVER TRANSPLANTATION, 2005, 11 (09) : 1064 - 1072
  • [7] Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results
    Hodge, EE
    Reich, DJ
    Clavien, PA
    Kim-Schluger, L
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1546 - 1547
  • [8] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [9] Individualisation of mycophenolate mofetil dose in renal transplant recipients
    van Hest, RM
    Hesselink, DA
    Vulto, AG
    Mathot, RAA
    van Gelder, T
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (04) : 361 - 376
  • [10] Dose Proportionality of Mycophenolate Mofetil in Renal Transplant Recipients
    de Winter, Brenda C. M.
    van Gelder, Teun
    Sombogaard, Ferdi
    van Hest, Reinier M.
    Mathot, Ron A. A.
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 613 - 613